Oramed Pharmaceuticals (ORMP) EBIT Margin (QoQ) (2016 - 2023)
Oramed Pharmaceuticals (ORMP) EBIT Margin (QoQ) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Oramed Pharmaceuticals | 196.17 Mn | 196.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 21,952.00 |
| Mar 31, 2023 | 58,151.00 |
| Dec 31, 2022 | -16,276.00 |
| Sep 30, 2022 | 49,318.00 |
| Jun 30, 2022 | -443.00 |
| Nov 30, 2019 | -1,604.00 |
| Aug 31, 2019 | 25,360.00 |
| May 31, 2019 | -6,221.00 |
| Feb 28, 2019 | 15,269.00 |
| Nov 30, 2018 | -17,789.00 |
| Aug 31, 2018 | 22,431.00 |
| May 31, 2018 | -21,978.00 |
| Feb 28, 2018 | -6,793.00 |
| Nov 30, 2017 | 1,451.00 |
| Aug 31, 2017 | -11,238.00 |
| May 31, 2017 | 20,147.00 |
| Feb 28, 2017 | -15,762.00 |
| Nov 30, 2016 | 427,572.00 |
| Aug 31, 2016 | -596,332.00 |
| May 31, 2016 | 282,408.00 |